Feature

Friendlier regulatory environment expected

Previously warned on pharma dividends

Housebuilders and retailers

Accounts for 24% of our energy needs

A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.

Our video series continues

General Election 2017

Central bank action has reduced volatility

Seen record inflows

Amid the attention focused on the recent downgrade of China, it is easy to forget that Indonesia was upgraded the week beforehand, when Standard & Poor's became the third and last of the major agencies to rate the country as investment grade (BBB-).